Marin Veldic, MD

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.

  • 3Articles
  • 9.6KReads1
  • 2015–2026Active
  • 36Collaborators
  • 59Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Marin Veldic, MD, is affiliated with the Department of Psychiatry and Psychology at the Mayo Clinic in Rochester, Minnesota. The author's publications from 2015 to 2026 focus on child and adolescent psychiatry, major depressive disorder, and genetics. Topics studied include treatment-resistant depression, genetic risk factors in early-onset bipolar disorder, and the relationship between serotonin transporter gene variants and antidepressant-induced mania. Frequent collaborators include Mark A. Frye, Alfredo B. Cuellar-Barboza, Jennifer R. Geske, Joanna M. Biernacka, and Paul E. Croarkin.

Publications

JCP
Next-Step Treatment Options for Treatment-Resistant Depression
Consensus Statement

Next-Step Treatment Options for Treatment-Resistant Depression

January 21, 2026

Strong consensus emerged for augmentation with second-generation antipsychotics, TMS, and ketamine/esketamine in the base vignette. Preferences shifted to include non-augmentative antidepressants and ECT based on patient characteristics.
, , , et al
JCP
Original Research

Genetics of Early-Onset Bipolar Disorder

February 14, 2017

Early-onset bipolar disorder may represent a distinct phenotype with greater severity, but the genetics of it are still poorly understood. This study used candidate genetic risk score analysis to...
, , , et al
JCP
Original Research

Clinical Risk Factors and Serotonin Transporter Gene Variants Associated With Antidepressant-Induced Mania

January 6, 2015

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe